In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 30 for your search:
At Hospital/Institution:  Presbyterian - St. Luke's Medical Center
Keywords/Phrases:  leukemia
Trial Status:  Active
Start Over
        Show
1.

Phase: No phase specified
Type: Tissue collection/Repository
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000357586, ECOG-E3903, E3903, NCT00897767

2.

Phase: Phase III
Type: Behavioral study, Treatment
Status: Active
Age: 1 to under 31
Sponsor: NCI
Protocol IDs: NCI-2009-00307, CDR0000514500, COG-AALL0434, AALL0434, U10CA098543, NCT00408005

3.

Phase: Phase II
Type: Treatment
Status: Active
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 2239.00, NCI-2009-01551, P30CA015704, FHCRC-2239.00, 6722, FHCRC-IR-6722, NCT00723099

4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Under 30
Sponsor: NCI
Protocol IDs: NCI-2011-02670, COG-AAML1031, CDR0000701850, AAML1031, U10CA098543, NCT01371981

5.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CX-839-003, NCT02071927

6.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SCRI CLL 18, NCT01848145

7.

Phase: No phase specified
Type: Health services research, Tissue collection/Repository
Status: Active
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: AALL08B1, NCI-2011-02235, CDR0000674844, COG-AALL08B1, U10CA098543, NCT01142427

8.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 and under at diagnosis
Sponsor: NCI, Other
Protocol IDs: AALL0631, NCI-2009-00313, COG-AALL0631, CDR0000573996, U10CA098543, NCT00557193

9.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 1 to < 10
Sponsor: NCI, Other
Protocol IDs: AALL0932, NCI-2011-02599, CDR0000683227, U10CA098543, COG-AALL0932, NCT01190930

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 50 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02621, CDR0000690286, CALGB-10701, CALGB 10701/CTSU C10701, U10CA031946, P30CA014236, NCT01256398

11.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 3 months to 30 years
Sponsor: NCI, Other
Protocol IDs: ACCL0933, NCI-2011-02640, CDR0000695748, COG-ACCL0933, U10CA095861, NCT01307579

12.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 60 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000659585, ECOG-E2906, E2906, NCT01041703

13.

Phase: No phase specified
Type: Tissue collection/Repository
Status: Active
Age: Under 31
Sponsor: NCI, Other
Protocol IDs: CDR0000491159, COG-AALL05B1, AALL05B1, NCT00897325

14.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and under
Sponsor: NCI, Other
Protocol IDs: ANHL1131, NCI-2012-01963, CDR0000732604, U10CA098543, COG-ANHL1131, NCT01595048

15.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2010LSUC043, MT2010-06, P01CA111412, NCT01288222

16.

Phase: No phase specified
Type: Tissue collection/Repository
Status: Active
Age: 0 months to 30 year
Sponsor: NCI, Other
Protocol IDs: ABTR01B1, NCI-2009-00324, CDR0000271415, COG-ABTR01B1, U10CA098543, NCT00898079

17.

Phase: No phase specified
Type: Health services research, Supportive care
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: 10-CBA, NCT01351545

18.

Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: ALTE05N1, NCI-2009-00382, CDR0000590123, U10CA098543, COG-ALTE05N1, NCT00736749

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2206.00, NCI-2010-02222, P30CA015704, P01CA018029, NCT01251575

20.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: not specified
Sponsor: NCI, Other
Protocol IDs: 2448.00, NCI-2010-02035, P30CA015704, P01CA018029, NCT01231412

21.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Tissue collection/Repository
Status: Active
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000478867, COG-ABTR04B1, ABTR04B1, NCT00898755

22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 0610-01, NCT01949883

23.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CX-839-002, NCT02071888

24.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-01173, CDR0000634119, U10CA021115, ECOG-E2905, E2905, NCT00843882

25.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000588879, CALGB-30610, RTOG 0538, U10CA031946, NCT00632853
1   
New Search